Market Research Logo

Global Chronic Obstructive Pulmonary Disease Market Analysis 2016 - Forecast to 2022

Global Chronic Obstructive Pulmonary Disease Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Chronic Obstructive Pulmonary Disease". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
  • Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping mapping the key common trends
  • Company profiling covering the financials, recent activities and the future strategies
  • Supply chain trends mapping the recent advancements
  • Strategic recommendations for the new entrants


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
3.5 Pipeline Analysis
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Chronic Obstructive Pulmonary Disease Market by Product
5.1 Introduction
5.2 Advair Diskus – GlaxoSmithKline
5.3 Combivent– Boehringer Ingelheim
5.4 Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc)
5.5 Arcapta/Onbrez Breezhaler – Novartis
5.6 Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc.
5.7 Foradil – Novartis (Co-marketed by Novartis and Schering Corporation)
5.8 Seebri Breezhaler – Novartis
5.9 Daliresp – Nycomed
5.10 Striverdi Respimat – Boehringer Ingelheim
5.11 Anoro
5.12 Striverdi Respimat
5.13 Duaklir Genuair
5.14 Breo
5.15 Incruse
5.16 Stiolto Respimat
5.17 Ultibro
5.18 Tudorza Pressair
6 Geographical Segmentation
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.2 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 RoW
6.4.1 Latin America
6.4.2 Middle East
6.4.3 Africa
6.4.4 Others
7 Vendor Landscaping
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
8 Company Profiles
8.1 GlaxoSmithKline
8.1.1 Business Overview
8.1.2 SWOT Analysis
8.1.3 Financial Overview
8.1.4 Strategy
8.1.5 Key Activities
8.2 Boehringer Ingelheim
8.3 Nycomed
8.4 Novartis
8.5 AstraZeneca
8.6 Rottapharm | Madaus
8.7 Theravance
8.8 Nucala
9 Appendix
10 Disclaimer
List of Tables
Table 1 Global Chronic Obstructive Pulmonary Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Chronic Obstructive Pulmonary Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 3 Global Advair Diskus – GlaxoSmithKline Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Combivent– Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 5 Global Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc) Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Arcapta/Onbrez Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc. Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Foradil – Novartis (Co-marketed by Novartis and Schering Corporation) Market Analysis, by Region, 2013-2022 ($MN)
Table 9 Global Seebri Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Daliresp – Nycomed Market Analysis, by Region, 2013-2022 ($MN)
Table 11 Global Striverdi Respimat – Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Anoro Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Striverdi Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Duaklir Genuair Market Analysis, by Region, 2013-2022 ($MN)
Table 15 Global Breo Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Incruse Market Analysis, by Region, 2013-2022 ($MN)
Table 17 Global Stiolto Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 18 Global Ultibro Market Analysis, by Region, 2013-2022 ($MN)
Table 19 Global Tudorza Pressair Market Analysis, by Region, 2013-2022 ($MN)
Table 20 North America Chronic Obstructive Pulmonary Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 21 North America Chronic Obstructive Pulmonary Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 22 North America Advair Diskus – GlaxoSmithKline Market Analysis, by Region, 2013-2022 ($MN)
Table 23 North America Combivent– Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 24 North America Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc) Market Analysis, by Region, 2013-2022 ($MN)
Table 25 North America Arcapta/Onbrez Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 26 North America Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc. Market Analysis, by Region, 2013-2022 ($MN)
Table 27 North America Foradil – Novartis (Co-marketed by Novartis and Schering Corporation) Market Analysis, by Region, 2013-2022 ($MN)
Table 28 North America Seebri Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 29 North America Daliresp – Nycomed Market Analysis, by Region, 2013-2022 ($MN)
Table 30 North America Striverdi Respimat – Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 31 North America Anoro Market Analysis, by Region, 2013-2022 ($MN)
Table 32 North America Striverdi Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 33 North America Duaklir Genuair Market Analysis, by Region, 2013-2022 ($MN)
Table 34 North America Breo Market Analysis, by Region, 2013-2022 ($MN)
Table 35 North America Incruse Market Analysis, by Region, 2013-2022 ($MN)
Table 36 North America Stiolto Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 37 North America Ultibro Market Analysis, by Region, 2013-2022 ($MN)
Table 38 North America Tudorza Pressair Market Analysis, by Region, 2013-2022 ($MN)
Table 39 Europe Chronic Obstructive Pulmonary Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 40 Europe Chronic Obstructive Pulmonary Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 41 Europe Advair Diskus – GlaxoSmithKline Market Analysis, by Region, 2013-2022 ($MN)
Table 42 Europe Combivent– Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 43 Europe Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc) Market Analysis, by Region, 2013-2022 ($MN)
Table 44 Europe Arcapta/Onbrez Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 45 Europe Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc. Market Analysis, by Region, 2013-2022 ($MN)
Table 46 Europe Foradil – Novartis (Co-marketed by Novartis and Schering Corporation) Market Analysis, by Region, 2013-2022 ($MN)
Table 47 Europe Seebri Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 48 Europe Daliresp – Nycomed Market Analysis, by Region, 2013-2022 ($MN)
Table 49 Europe Striverdi Respimat – Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 50 Europe Anoro Market Analysis, by Region, 2013-2022 ($MN)
Table 51 Europe Striverdi Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 52 Europe Duaklir Genuair Market Analysis, by Region, 2013-2022 ($MN)
Table 53 Europe Breo Market Analysis, by Region, 2013-2022 ($MN)
Table 54 Europe Incruse Market Analysis, by Region, 2013-2022 ($MN)
Table 55 Europe Stiolto Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 56 Europe Ultibro Market Analysis, by Region, 2013-2022 ($MN)
Table 57 Europe Tudorza Pressair Market Analysis, by Region, 2013-2022 ($MN)
Table 58 Asia Pacific Chronic Obstructive Pulmonary Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 59 Asia Pacific Chronic Obstructive Pulmonary Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 60 Asia Pacific Advair Diskus – GlaxoSmithKline Market Analysis, by Region, 2013-2022 ($MN)
Table 61 Asia Pacific Combivent– Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 62 Asia Pacific Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc) Market Analysis, by Region, 2013-2022 ($MN)
Table 63 Asia Pacific Arcapta/Onbrez Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 64 Asia Pacific Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc. Market Analysis, by Region, 2013-2022 ($MN)
Table 65 Asia Pacific Foradil – Novartis (Co-marketed by Novartis and Schering Corporation) Market Analysis, by Region, 2013-2022 ($MN)
Table 66 Asia Pacific Seebri Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 67 Asia Pacific Daliresp – Nycomed Market Analysis, by Region, 2013-2022 ($MN)
Table 68 Asia Pacific Striverdi Respimat – Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 69 Asia Pacific Anoro Market Analysis, by Region, 2013-2022 ($MN)
Table 70 Asia Pacific Striverdi Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 71 Asia Pacific Duaklir Genuair Market Analysis, by Region, 2013-2022 ($MN)
Table 72 Asia Pacific Breo Market Analysis, by Region, 2013-2022 ($MN)
Table 73 Asia Pacific Incruse Market Analysis, by Region, 2013-2022 ($MN)
Table 74 Asia Pacific Stiolto Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 75 Asia Pacific Ultibro Market Analysis, by Region, 2013-2022 ($MN)
Table 76 Asia Pacific Tudorza Pressair Market Analysis, by Region, 2013-2022 ($MN)
Table 77 RoW Chronic Obstructive Pulmonary Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 78 RoW Chronic Obstructive Pulmonary Disease Market Analysis, by Product, 2013-2022 ($MN)
Table 79 RoW Advair Diskus – GlaxoSmithKline Market Analysis, by Region, 2013-2022 ($MN)
Table 80 RoW Combivent– Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 81 RoW Symbicort – AstraZeneca (Co-promotion with Astellas Pharma Inc) Market Analysis, by Region, 2013-2022 ($MN)
Table 82 RoW Arcapta/Onbrez Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 83 RoW Spiriva – Boehringer Ingelheim Pharmaceuticals, Pfizer Inc. Market Analysis, by Region, 2013-2022 ($MN)
Table 84 RoW Foradil – Novartis (Co-marketed by Novartis and Schering Corporation) Market Analysis, by Region, 2013-2022 ($MN)
Table 85 RoW Seebri Breezhaler – Novartis Market Analysis, by Region, 2013-2022 ($MN)
Table 86 RoW Daliresp – Nycomed Market Analysis, by Region, 2013-2022 ($MN)
Table 87 RoW Striverdi Respimat – Boehringer Ingelheim Market Analysis, by Region, 2013-2022 ($MN)
Table 88 RoW Anoro Market Analysis, by Region, 2013-2022 ($MN)
Table 89 RoW Striverdi Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 90 RoW Duaklir Genuair Market Analysis, by Region, 2013-2022 ($MN)
Table 91 RoW Breo Market Analysis, by Region, 2013-2022 ($MN)
Table 92 RoW Incruse Market Analysis, by Region, 2013-2022 ($MN)
Table 93 RoW Stiolto Respimat Market Analysis, by Region, 2013-2022 ($MN)
Table 94 RoW Ultibro Market Analysis, by Region, 2013-2022 ($MN)
Table 95 RoW Tudorza Pressair Market Analysis, by Region, 2013-2022 ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report